Biotype 2 of the Russian wheat aphid, Diuraphis noxia (Mordvilko), was identified in the United States in 2003 and is virulent to all commercially available cultivars of winter wheat, Triticum aestivum L., that are resistant to biotype 1. We compared the development and reproduction of biotype 2 D. noxia at 21.7 ± 0.12°C on ‘Trego’ (PI 612576), a susceptible commercial cultivar, and on lines CI 2401 and 03GD1378027 that represent putative resistance sources. CI 2401 is a pure wheat line originating in the former USSR (Tajikistan), whereas 03GD1378027 is a USDA–ARS breeding line originally developed from crosses with a South African line that carried a large rye translocation conferring D. noxia resistance. Both lines previously showed resistance to biotype 1 and are currently being used in the development of D. noxia-resistant wheat cultivars. Both solitary apterous virginoparae of biotype 2 and their progeny experienced a reduction in survival and prolonged developmental times on CI 2401 and 03GD1378027 compared with Trego, but the former lines did not differ significantly from each other with respect to either measure of aphid performance. Progeny developed faster than did their foundress mothers on CI 2401 and Trego, but not on 03GD1378027. Mean foundress fecundity did not differ between CI 2401 and 03GD1378027 but was reduced on these lines relative to Trego. Foundresses also were more often found off plants of CI 2401 and 03GD1378027 than Trego. Estimates of intrinsic rate of increase were higher on Trego than on either CI 2401 or 03GD1378027, the latter two lines yielding similar values. The negative impacts of CI 2401 and 03GD1378027 on development and reproduction of biotype 2 indicate that these lines represent sources of resistance effective against this biotype.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 99 • No. 2